Skip to main content

FBTDX

ETF
FBTDX · UNKNOWN · 82 holdings
KWD 154.51
▲ KWD 2.65 (1.75%)
Day Range
52-Week Range
Volume
فتح —
متوسط 50 يوم / 200 يوم
متوسط 50 يوم / 200 يوم

About FBTDX

No description available for this ETF.

Fund Details

Expense Ratio
Inception Date
Prev. Close
KWD 151.86
Exchange
UNKNOWN
Currency
USD
Holdings As Of
Apr 10, 2026
Tracked Holdings
58.5%
HHI Score
345.62
Top Sector
Healthcare (76.110063%)

Performance

Moderate (28.8%) ↘ Decelerating
1W
▲ 2.82%
1M
▲ 3.82%
3M
▲ 6.33%
6M
▲ 18.11%
YTD
▲ 5.65%
1Y
▲ 67.86%
3Y
▲ 56.98%

1M return (+3.82%) is stronger than 1W (+2.82%) — gains are slowing

Price History

Concentration Risk

50.16% Moderately Concentrated
Diversified Concentrated

The top 10 holdings represent 50.16% of the fund. This ETF is heavily concentrated — performance is largely driven by a few stocks.

Top Holdings Today

Weighted by position size
VRTX
▼ -0.07%
GILD
▲ 0.62%
AMGN
▲ 1.90%
REGN
▼ -1.26%
ASND
▲ 4.85%
ARGX
▲ 1.31%
PTCT
▲ 0.21%
Weighted avg. of top holdings ▲ 1.03%

Sector Allocation

Healthcare
76.11%

Top 10 Holdings

50.16% of fund
VRTX Vertex Pharmaceuticals, Inc.
7.99%
GILD Gilead Sciences, Inc.
7.56%
AMGN Amgen, Inc.
7.38%
REGN Regeneron Pharmaceuticals, Inc.
5.07%
ASND Ascendis Pharma A/S
4.90%
ARGX Argenx SE
4.09%
Jazz Pharmaceuticals Jazz Pharmaceuticals plc
3.92%
Merus NV Merus NV
3.21%
PTCT PTC Therapeutics, Inc.
3.10%
Benitec Biopharma, I Benitec Biopharma, Inc.
2.94%
Other positions
2.73%

All Holdings (82)

Top 10: 50.16% of fund
# Ticker Name Weight Shares Market Value
1 VRTX Vertex Pharmaceuticals, Inc. 7.99% 111,026 56.57 M
2 GILD Gilead Sciences, Inc. 7.56% 502,212 53.51 M
3 AMGN Amgen, Inc. 7.38% 179,411 52.19 M
4 REGN Regeneron Pharmaceuticals, Inc. 5.07% 59,922 35.88 M
5 ASND Ascendis Pharma A/S 4.90% 203,340 34.66 M
6 ARGX Argenx SE 4.09% 44,836 28.93 M
7 Jazz Pharmaceuticals Jazz Pharmaceuticals plc 3.92% 237,159 27.74 M
8 Merus NV Merus NV 3.21% 499,698 22.74 M
9 PTCT PTC Therapeutics, Inc. 3.10% 440,811 21.97 M
10 Benitec Biopharma, I Benitec Biopharma, Inc. 2.94% 1.53 M 20.78 M
Showing top 10 of 82 holdings · Listed: 97.27% · 2.73% in other positions

Related ETFs